Real-time enrollment status for this hiv infections clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:54 PM UTC
| NCT Number | NCT03684655 |
| Recruiting Status | Recruiting |
| Condition | HIV Infections |
| Phase | PHASE2 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | CellSight Technologies, Inc. |
| Last Updated on CT.gov | October 24, 2024 (Oct 24, 2024) |
As of July 19, 2026: Clinical trial NCT03684655 is currently recruiting participants. This phase2 study for hiv infections is actively seeking new participants at 1 location across the United States. The study is sponsored by CellSight Technologies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03684655 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03684655 was last updated Oct 24, 2024 (October 24, 2024). HelloStudys verifies this status automatically.